INTERGRATED DIA.H DL 025

Research INTERGRATED DIA.H DL 025 (8I8) on Bullrun: market cap EUR 268.04M, P/E 10.6, dividend yield 5.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 268.04M; P/E is 10.6; dividend yield is 5.2%.

Peer valuation comparison

Latest P/E is 10.55x versus a Healthcare sector median of 24.46x (56.9% below).

Latest dividend yield is 5.2% versus a Healthcare sector median of 2.11% (146.4% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EGP 7.86BEGP 1.26BEGP 1.38B42.7%2.17EGP 1.67BEGP 1.61BEGP 3.38B
FY2024EGP 5.72BEGP 1.08BEGP 1.34B38.1%n/aEGP 1.19BEGP 1.47BEGP 2.71B
FY2023EGP 4.12BEGP 510.30MEGP 217.73M37.0%0.85EGP 674.25MEGP 1.18BEGP 2.68B
FY2022EGP 3.61BEGP 541.11M-EGP 100.11M40.6%0.9EGP 648.51MEGP 1.18BEGP 2.15B
FY2021n/an/an/an/a2.35n/an/an/a

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24EUR 268.04M10.61.9%0.01

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.01 EUR, yield 5.2%.

YearDividends/share
FY20250.01 EGP
FY20220.1 EGP
FY20210.04 EGP

About INTERGRATED DIA.H DL 025

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is INTERGRATED DIA.H DL 025's market cap?

INTERGRATED DIA.H DL 025's market capitalization is EUR 268.04M.

What is INTERGRATED DIA.H DL 025's P/E ratio?

INTERGRATED DIA.H DL 025's price-to-earnings (P/E) ratio is 10.6.

Does INTERGRATED DIA.H DL 025 pay a dividend?

INTERGRATED DIA.H DL 025 has a dividend yield of 5.2%.

What does INTERGRATED DIA.H DL 025 do?

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics.